Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

News

New Endometriosis podcast launched: "Unheard of"

Listen now to the first episode ‘Unheard of – The hidden voice of Endometriosis.’ A bold new podcast series co-hosted by DPhil students Danielle Perro and Magda Mareckova, it seeks answers to the biggest questions posed by the Endometriosis community.

A world leading study involving over 260,000 participants led by Prof Kazem Rahimi, has sought to resolve the long debated issue about whether using antihypertensive medication heightens the chance of developing cancer.

Blood pressure lowering drugs not found to increase risk of cancer

A world leading study involving over 260,000 participants has sought to resolve the long debated issue about whether using antihypertensive medication heightens the chance of developing cancer.

Research uncovers link between the timing of fetal head growth patterns and subsequent child development

Vaccitech Ltd, a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer, today announced the dosing of the first patient as part of the HPV001 clinical study.

First patient dose in HPV clinical trial

Vaccitech Ltd, a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer, today announced the dosing of the first patient as part of the HPV001 clinical study.

Professor Cecilia Lindgren appointed Director of the Big Data Institute

Professor Cecilia Lindgren (Prof of Genomic Endocrinology & Metabolism at the Nuffield Dept of Women's & Reproductive Health) has been appointed as the new Director of the University of Oxford’s Big Data Institute.

Celebrating International Women's Day

100 years since women were admitted as full members of the University of Oxford, women now hold vital posts at all levels of this institution.

This is the core mission of Singula Bio – a new Oxford spinout that will develop neoantigen-based individualised cell therapies to use against difficult-to-treat solid malignancies such as ovarian cancer.

Singula Bio provides new hope for cancer with diverse, individualised therapies

Cancer

The Oxford spinout will draw on a multi-discipline approach for therapies which work with a patient to eliminate cancer.

The chemical structures of the four modified cytosine bases in DNA: 5mC, 5hmC, 5fC and 5caC.

New sequencing methods for distinguishing DNA modifications

A collaboration between Prof Ahmed's group at the Nuffield Dept of Women's & Reproductive Health and Dr Chunxiao Song’s lab at the Ludwig Institute for Cancer Research, has established new sequencing methods for distinguishing DNA modifications. The paper: "Subtraction-free and bisulfite-free specific sequencing of 5-methylcytosine and its oxidized derivatives at base resolution" has been published in Nature Communications.

Europe's first living Biobank has been created - it stores the reproductive cells of endangered animals to save them from extinction. Prof Suzannah Williams is working with the charity Nature’s SAFE as their Chief Scientist. She commented: “Nature’s SAFE has true functional relevance by proactively preserving cells and reproductive tissues from endangered and threatened species, whilst numbers are viable and genetic diversity is high.

Europe’s first living biobank stores reproductive cells to save animals from extinction

Nature’s SAFE, Europe’s first Living Biobank dedicated to preserving endangered animals has been launched with the mission to save animals from extinction, by harnessing regeneration and reproductive technologies developed via domestic animal breeding.

The new, Oxford-developed method for subtyping ovarian cancer has been validated in a recent collaboration between the University of Oxford and Imperial College London. Dubbed the ‘Oxford Classic’, researchers have demonstrated that it enables the accurate prediction of patient disease outcome, as well as the development of new targeted cancer therapies.

Accurate predictions of ovarian cancer outcome possible with new classification system

The new, Oxford-developed method for subtyping ovarian cancer has been validated in a recent collaboration between the University of Oxford and Imperial College London. Dubbed the ‘Oxford Classic’, researchers have demonstrated that it enables the accurate prediction of patient disease outcome, as well as the development of new targeted cancer therapies.

Professor Terry Dwyer, from the Nuffield Department of Women’s & Reproductive Health is lead author of a study to determine if physical activity reduces cardiovascular disease risk.

No limit to the benefits of exercise in reducing the risk of cardiovascular disease

A new study led by the University of Oxford on over 90,000 participants shows that there is no upper threshold to the benefits of exercise in reducing the risk of cardiovascular disease – ‘every move counts towards better cardiovascular health.

Congratulations to Prof Aris Papageorghiou who launched an exciting new initiative called scan.academy during the COVID-19 lockdown. Scan.academy is dedicated to improving obstetric ultrasound through state-of-the-art education and offers free masterclass webinars by world class experts in women's health.

Scan academy webinars

Celebrating the successful launch of scan.academy - an initiative dedicated to improving obstetric ultrasound through state-of-the-art education.

A fantastic achievement for DPhil student Toluwalase Awoyemi from Prof Vatish's research group! He is recognised with an Africa 35.35 Award - a celebration of the top 35 leading young changemakers under 35 in Africa in 2020.

Africa’s 35 Under 35 Award

A fantastic achievement for DPhil student Toluwalase Awoyemi from Prof Vatish's research group! He is recognised with an Africa 35.35 Award - a celebration of the top 35 leading young changemakers under 35 in Africa in 2020.

Congratulations to Magda Marečková! Our DPhil student and student committee president has won this year's special Young Scientist Award at the Fast Forward Science 2020 web-video competition. She wins for her compelling video: "Heavy periods, intense pain and no one to talk to. Could you have Endometriosis?

Young Scientist Award

Congratulations to Magda Marečková! Our DPhil student and student committee president has won this year's special prize, the Special Young Scientist Award at the Fast Forward Science 2020 web-video competition. She wins for her compelling video: "Heavy periods, intense pain and no one to talk to. Could you have Endometriosis?

Dr Joris Hemelaar, University Research Lecturer and expert in maternal HIV infection at the Nuffield Department of Women's & Reproductive Health, has published a new article: "Global and regional epidemiology of HIV-1 recombinants in 1990-2015" in the Lancet HIV.

HIV-1 recombinants: The challenges of increasing genetic diversity

Dr Joris Hemelaar, University Research Lecturer and expert in maternal HIV infection at the Nuffield Department of Women's & Reproductive Health, published a new article: "Global and regional epidemiology of HIV-1 recombinants in 1990-2015" in the Lancet HIV.

Celebrating new full professors

Congratulations are in order for three of our professors (Papageorghiou, Rahimi and Vatish) who have each been awarded full professor titles in this year's University Recognition of Distinction exercise.

The department's senior fellow in perinatal health Dr Jane Hirst – who leads global research into gestational diabetes mellitus (GDM), preterm birth and stillbirth – has been awarded a Fellowship of the UK Research and Innovation (UKRI) Future Leaders. Congratulations!

Dr Jane Hirst awarded Fellowship of the UKRI Future Leaders

The department's senior fellow in perinatal health Dr Jane Hirst – who leads global research into gestational diabetes mellitus (GDM), preterm birth and stillbirth – has been awarded a Fellowship of the UK Research and Innovation (UKRI) Future Leaders.

The GaPP2 trial - a multi-centre randomised controlled trial of the efficacy of gabapentin for the management of chronic pelvic pain in women, finds the drug is ineffective. The research findings have been published in The Lancet.

Common pelvic pain drug is ineffective

The GaPP2 trial - a multi-centre randomised controlled trial of the efficacy of gabapentin for the management of chronic pelvic pain in women, finds the drug is ineffective.

The OxNNet toolkit led by Prof Sally Collins in the Nuffield Department of Women's & Reproductive Health, will receive a share of £50M funding from the NIHR. This exciting project seeks to develop a fully automated ultrasound tool to screen for fetal growth restriction (FGR) in the first trimester.

NIHR funds groundbreaking Oxford University research into using AI to predict growth restricted babies

A number of cutting edge artificial intelligence (AI) technologies will be tested and scaled in the NHS, as the first winners of the AI in Health and Care Award, sharing approximately £50m.

Nautilus Academic Award - Jossey Agyeman-Duah

DPhil student Jossey Agyeman-Duah wins an Nautilus Academic Award from Green Templeton College. The award recognises students who have gone beyond the call of duty to make an outstanding contribution to improving the college environment.

Load More